MAZE experienced a dramatic financial deterioration with net income swinging from $52.2M profit to -$131.1M loss while simultaneously raising significant capital that boosted stockholders' equity from -$311.2M to $355.0M.
The company appears to have undergone a major financial restructuring or recapitalization event, with operating performance collapsing by over 340% while balance sheet strength dramatically improved through what likely represents substantial new equity financing. This combination suggests either a turnaround attempt following severe operational challenges or a significant business model pivot requiring heavy investment.
MAZE's financial profile shows a tale of two stories - catastrophic operational performance with net income dropping 351% to -$131.1M and operating cash flow turning negative by -$111.9M, coupled with a massive balance sheet strengthening that moved stockholders' equity from deeply negative -$311.2M to positive $355.0M and nearly doubled total assets to $397.1M. The 30% increase in R&D spending alongside the equity infusion suggests the company is investing heavily in a turnaround or transformation strategy, but current operations are burning cash at an unsustainable rate. This financial profile indicates either a company in the midst of a major restructuring following distress or one making significant strategic investments that have yet to generate returns.
Net income declined 351% — review whether driven by operations, interest costs, or non-recurring items.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Operating cash flow fell 247.4% — earnings quality concerns; investigate working capital changes and non-cash items.
Equity base grew 214.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets grew 73.4% — improving short-term liquidity or inventory/receivables build.
Asset base grew 65.1% — expansion through organic growth, acquisitions, or capital deployment.
Capex reduced 30.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
R&D investment increased 29.9% — signals commitment to future product development, though near-term margin impact.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →